Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
sCiEnTiFiC proGrAMME<br />
Sunday 13 May 2012<br />
11:40 > PRIMO: a graphical environment for the automatic simulation<br />
of Varian and Elekta linacs with PENELOPE<br />
SPEaKER: L. Brualla (Germany) SP-0619<br />
SYMPOSIUM<br />
CoMpArison sTUdiEs: onGoinG rEsEArCh<br />
lEaRning ObJECTivES:<br />
1. To outline the importance of comparison studies<br />
2. To outline the survival and toxicity from published studies<br />
3. To understand to define the margin for rectal cancer from GTV to PTV<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 188 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
11:00 - 12:00 • Room 118-119<br />
ChaiR: A. Osztavics (Austria)<br />
CO-ChaiR: TBC<br />
11:00 > ICORG 09-06 An ongoing prospective randomised trial comparing<br />
3D RT with IMRT for the treatment of endometrial cancer<br />
SPEaKER: L. O’Sullivan (Ireland Republic of) SP-0620<br />
11:20 > 3-years follow-up of a moderate hypofractionation scheme<br />
with endorectal balloon for EBRT of the prostate<br />
SPEaKER: G. McColl (The Netherlands) SP-0621<br />
11:40 > Shape variation of the clinical target volume in rectal cancer:<br />
comparison between short-course and long-course RT<br />
SPEaKER: J. Nijkamp (The Netherlands) SP-0622<br />
DEBATE<br />
ThE hoUsE bEliEVEs ThAT bioloGiCAl opTiMisATion sUpErsEdEs<br />
physiCAl opTiMisATion<br />
lEaRning ObJECTivES:<br />
1. To understand the current parameters for treatment plan optimization, their advantages<br />
and their shortcomings<br />
2. To realize that different opinions exist on the validity of the current biological<br />
models for treatment plan optimization<br />
Sunday 13 May 2012<br />
abS. numbER<br />
3. To understand the general value which lies in the concept of biological treatment<br />
plan optimization and, based on this, the value of scientific research in this field as<br />
well as the clinical need to closely and critically follow the evidence<br />
12:00 - 12:45 • Room 112<br />
ChaiR: M. Baumann (Germany)<br />
12:00 > For the motion<br />
SPEaKER: J. Deasy (USA) SP-0623<br />
12:20 > Against the motion - biological optimization is still immature<br />
SPEaKER: D.R. Olsen (Norway) SP-0624<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 189<br />
sCiEnTiFiC proGrAMME<br />
eSTRO 31
Change language